Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Effert

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Acta Urologica Belgica|April 1, 1994
Basic research in prostate cancer: molecular biologyP J Effert, T G Strohmeyer
Urological Research|January 1, 1995
Theories on the metastatic process and possible therapeutic optionsP J Effert, T G Strohmeyer
World Journal of Urology|January 1, 1996
Current and future strategies to block tumor angiogenesis, invasion, and metastasisP J Effert, G Gastl, T Strohmeyer
The Journal of Urology|March 1, 1992
Alterations of the P53 gene are associated with the progression of a human prostate carcinomaP J Effert, A Neubauer, P J Walther, et al.
The Journal of Urology|July 1, 1993
p53 gene alterations in human prostate carcinomaP J Effert, R H McCoy, P J Walther, et al.
International Journal of Cancer|October 21, 1992
Expression of the matrix Gla protein in urogenital malignanciesE N Levedakou, T G Strohmeyer, P J Effert, et al.
European Urology|January 1, 1996
Clinical use of prostate-specific antigen and prostate-specific antigen density in the staging of patients with cancer of the prostateJ M Wolff, W Boeckmann, P J Effert, et al.
British Journal of Urology|July 1, 1995
Evaluation of patients with diseases of the prostate using prostate-specific antigen densityJ M Wolff, W Boeckmann, P J Effert, et al.
British Journal of Urology|September 1, 1996
Free-to-total prostate-specific antigen serum concentrations in patients with prostate cancer and benign prostatic hyperplasiaJ M Wolff, H Borchers, P J Effert, et al.
Anticancer Research|July 1, 1997
Increased discrimination between benign prostatic hyperplasia and prostate cancer through measurement of percentage free PSAJ M Wolff, W Boeckmann, P J Effert, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Acta Urologica Belgica|April 1, 1994
Basic research in prostate cancer: molecular biologyP J Effert, T G Strohmeyer
Urological Research|January 1, 1995
Theories on the metastatic process and possible therapeutic optionsP J Effert, T G Strohmeyer
World Journal of Urology|January 1, 1996
Current and future strategies to block tumor angiogenesis, invasion, and metastasisP J Effert, G Gastl, T Strohmeyer
The Journal of Urology|March 1, 1992
Alterations of the P53 gene are associated with the progression of a human prostate carcinomaP J Effert, A Neubauer, P J Walther, et al.
The Journal of Urology|July 1, 1993
p53 gene alterations in human prostate carcinomaP J Effert, R H McCoy, P J Walther, et al.
International Journal of Cancer|October 21, 1992
Expression of the matrix Gla protein in urogenital malignanciesE N Levedakou, T G Strohmeyer, P J Effert, et al.
European Urology|January 1, 1996
Clinical use of prostate-specific antigen and prostate-specific antigen density in the staging of patients with cancer of the prostateJ M Wolff, W Boeckmann, P J Effert, et al.
British Journal of Urology|July 1, 1995
Evaluation of patients with diseases of the prostate using prostate-specific antigen densityJ M Wolff, W Boeckmann, P J Effert, et al.
British Journal of Urology|September 1, 1996
Free-to-total prostate-specific antigen serum concentrations in patients with prostate cancer and benign prostatic hyperplasiaJ M Wolff, H Borchers, P J Effert, et al.
Anticancer Research|July 1, 1997
Increased discrimination between benign prostatic hyperplasia and prostate cancer through measurement of percentage free PSAJ M Wolff, W Boeckmann, P J Effert, et al.
Pageof 2